Company / Revenue per Share
Nurix Therapeutics, Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.11
FY2025
5-year range
$0.67 / $1.63
FY2021-FY2025
Trend
-1.1%
vs FY2024
Sector context
#102 of 154
Health Care
What the data says
At $1.11, Nurix Therapeutics, Inc.'s revenue per share ranks #102 of 154 in the Health Care sector. Declined from $1.63 to $1.11 over the past 2 years.
Based on SEC 10-K filings.
1.11 in FY2025 with a 5-year CAGR of -25.9%.
Declined from $1.63 to $1.11 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +18.4%
- 5-Year CAGR
- -25.9%
- 10-Year CAGR
- -
Sector benchmark
#102 of 154 in Health CareTop 66% of 154This company $1.11 Sector average $10.35
▼
-89.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 1.1% year-over-year.
- Ranks #102 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.11 | -1.1% |
| FY2024 | $1.12 | -31.4% |
| FY2023 | $1.63 | +145.0% |
| FY2022 | $0.67 | -16.8% |
| FY2021 | $0.80 | -83.8% |
| FY2020 | $4.96 | -47.6% |
| FY2019 | $9.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026